JUMPCAN(SH:600566) Zheng Quan Zhi Xing·2025-07-11 09:26Summary of Key Points Core Viewpoint - The announcement details Mr. Cao Fei's offer to acquire shares of Hubei Jichuan Pharmaceutical Co., Ltd., with a total of 350,841,357 shares being targeted for acquisition at a revised price of 24.85 yuan per share, down from 26.93 yuan per share [1][2]. Group 1: Offer Details - The offer is triggered as Mr. Cao Fei, through Jichuan Holdings and Tibet Jichuan Enterprise Management Co., Ltd., holds 56.07% of the company's shares, exceeding the 30% threshold that mandates a public offer [2]. - The offer period is set for 30 calendar days, starting from June 18, 2025, to July 17, 2025, with specific trading days where shareholders cannot withdraw their acceptance of the offer [2][4]. - The payment method for the acquisition is cash, and the offer is not intended to terminate the listing status of Jichuan Pharmaceutical [2][4]. Group 2: Acceptance and Withdrawal Procedures - Shareholders wishing to accept the offer must submit their applications through their designated securities companies during the offer period, with the effective number of shares based on their actual holdings [3]. - If shareholders wish to withdraw their acceptance, they must do so at least three trading days before the offer period ends, and the shares will be temporarily held by China Securities Shanghai Branch during this time [3][5]. - The company will provide updates on the progress of the offer and the number of shares accepted [2][4]. Group 3: Offer Statistics - As of July 10, 2025, a total of 4,100 shares have been accepted under the offer, representing approximately 0.0004% of the company's total share capital [5][6]. - The company will issue a separate announcement regarding the results of the offer and any subsequent clearing announcements after the offer period concludes [5][6].